References
- Akaike H. A new look at the statistical model identification. System identification and time-series analysis. IEEE Transactions on Automatic Control 1974; AC-19: 716–723
- Ao S., Shigu Y., Notsu Y., Kikuchi C., Yamaguchi I. (1990) Characterization of a novel aldose reductase inhibitor, FR74366. Proceedings, Japan-US Aldose Reductase Workshop. 1990, N. Sakamoto, J. H. Kinoshita, P. F. Kador, N. Hotta. Excerpta Medica, Amsterdam—New York—Oxford, 81–88
- Brazzell R. K., Park Y. H., Wooldridge C. B., McCue B., Barker R., Couch R., York B. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors. Drug Metabolism and Disposition 1990; 18: 435–440
- Cayen M. N., Hicks D. R., Ferdinandi E. S., Kraml M., Greselin E., Dvornik D. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys. Drug Metabolism and Disposition 1985; 13: 412–419
- Horrock D. L., Studier M. H. Two level plutonium-241 analysis by liquid scintillation technique. Analytical Chemistry 1985; 10: 1747–1750
- Metzler C. M., Elgring G. K., McEwsen A. J. A package of computer programs for pharmacokinetic modeling. Biometrics 1974; 30: 562–563
- Shah V. P., Wallance S. M., Reigeiman S. Microultrafiltration technique for drug-protein binding determination in plasma. Journal of Pharmaceutical Science 1974; 63: 1364–1367
- Tanaka Y., Sekiguchi M., Sawamoto T., Tokuma Y., Noda K. The metabolism of ARI, FR74366 in the rats and dog. Proceedings, Annual Meeting of the Pharmaceutical Society of Japan. 1991; Vol. 4: 134